The Zhitong Finance App learned that CMB International released a research report stating that it will raise the target price of Collumbotai Biotech (06990.HK) by 0.5% from HK$642.99 to HK$645.62, maintaining the “buy” rating.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.